The role of melatonin on miRNAs modulation in triple-negative breast cancer cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of melatonin on miRNAs modulation in triple-negative breast cancer cells
Authors
Keywords
Melatonin, MicroRNAs, Breast cancer, Cancer treatment, Cancer cell migration, Cell migration, Cell proliferation, Protein expression
Journal
PLoS One
Volume 15, Issue 2, Pages e0228062
Publisher
Public Library of Science (PLoS)
Online
2020-02-04
DOI
10.1371/journal.pone.0228062
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis
- (2017) Russel Reiter et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Melatonin-induced KiSS1 expression inhibits triple-negative breast cancer cell invasiveness
- (2017) Tae-Hun Kim et al. Oncology Letters
- Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines
- (2016) Bruna Victorasso Jardim-Perassi et al. Anti-Cancer Agents in Medicinal Chemistry
- Melatonin Regulates Angiogenic and Inflammatory Proteins in MDA-MB-231 Cell Line and in Co-culture with Cancer-associated Fibroblasts
- (2016) Larissa B. Maschio-Signorini et al. Anti-Cancer Agents in Medicinal Chemistry
- miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer
- (2016) F. Orso et al. CANCER RESEARCH
- Melatonin Represses Metastasis in Her2-Postive Human Breast Cancer Cells by Suppressing RSK2 Expression
- (2016) L. Mao et al. MOLECULAR CANCER RESEARCH
- MicroRNA-210 interacts with FBXO31 to regulate cancer proliferation cell cycle and migration in human breast cancer
- (2016) Jianting Long et al. OncoTargets and Therapy
- Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects
- (2016) Federica Mori et al. Oncotarget
- A summary for molecular regulations of miRNAs in breast cancer
- (2015) Shaymaa M.M. Yahya et al. CLINICAL BIOCHEMISTRY
- The Role of Hypoxia-Induced miR-210 in Cancer Progression
- (2015) Kyvan Dang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- miR-214 as a Key Hub that Controls Cancer Networks: Small Player, Multiple Functions
- (2015) Elisa Penna et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Melatonin uptake through glucose transporters: a new target for melatonin inhibition of cancer
- (2015) David Hevia et al. JOURNAL OF PINEAL RESEARCH
- Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression
- (2015) Thaiz Ferraz Borin et al. JOURNAL OF PINEAL RESEARCH
- MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway
- (2015) Jun-gang Zhang et al. Scientific Reports
- Upregulation of miRNA3195 and miRNA374b Mediates the Anti-Angiogenic Properties of Melatonin in Hypoxic PC-3 Prostate Cancer Cells
- (2015) Eun Jung Sohn et al. Journal of Cancer
- In vitro microenvironments to study breast cancer bone colonisation
- (2014) Anna V. Taubenberger ADVANCED DRUG DELIVERY REVIEWS
- miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2
- (2014) Emanuel Kronski et al. Molecular Oncology
- miR-150-5p Inhibits Hepatoma Cell Migration and Invasion by Targeting MMP14
- (2014) Tao Li et al. PLoS One
- Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review)
- (2014) SAMUEL COS et al. Oncology Letters
- The role of microRNA in resistance to breast cancer therapy
- (2014) Neil M. Robertson et al. Wiley Interdisciplinary Reviews-RNA
- Melatonin Anticancer Effects: Review
- (2013) Giuseppe Di Bella et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Breast cancer as a systemic disease: a view of metastasis
- (2013) A. J. Redig et al. JOURNAL OF INTERNAL MEDICINE
- The MicroRNA-148/152 Family: Multi-faceted Players
- (2013) Yue Chen et al. Molecular Cancer
- Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status
- (2013) Gianpiero Di Leva et al. PLoS Genetics
- Molecular mechanisms of melatonin’s inhibitory actions on breast cancers
- (2012) Sara Proietti et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Melatonin suppresses tumor progression by reducing angiogenesis stimulated by HIF-1 in a mouse tumor model
- (2012) Kil-Jung Kim et al. JOURNAL OF PINEAL RESEARCH
- Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin
- (2011) M. D. Mediavilla et al. CURRENT MEDICINAL CHEMISTRY
- microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C
- (2011) Elisa Penna et al. EMBO JOURNAL
- MicroRNA and gene expression analysis of melatonin-exposed human breast cancer cell lines indicating involvement of the anticancer effect
- (2011) Seung Eun Lee et al. JOURNAL OF PINEAL RESEARCH
- Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin
- (2010) Steven M. Hill et al. BREAST CANCER RESEARCH AND TREATMENT
- Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis
- (2010) Ming Shi et al. CANCER AND METASTASIS REVIEWS
- miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer
- (2010) Antonis Giannakakis et al. CANCER BIOLOGY & THERAPY
- MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT
- (2010) Zhan Zhang et al. CELL CYCLE
- Neurotoxins: Free Radical Mechanisms and Melatonin Protection
- (2010) Russel J. Reiter et al. Current Neuropharmacology
- Melatonin signaling and cell protection function
- (2010) Francesca Luchetti et al. FASEB JOURNAL
- In vitro and in vivo antitumor activity of melatonin receptor agonists
- (2010) Lulu Mao et al. JOURNAL OF PINEAL RESEARCH
- International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin Receptors
- (2010) M. L. Dubocovich et al. PHARMACOLOGICAL REVIEWS
- Molecular Mechanisms of Melatonin Anticancer Effects
- (2009) Steven M. Hill et al. INTEGRATIVE CANCER THERAPIES
- Melatonin protects the mitochondria from oxidative damage reducing oxygen consumption, membrane potential, and superoxide anion production
- (2008) Ana López et al. JOURNAL OF PINEAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started